Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity

摘要

Objective: To investigate chest wall pain in patients with peripheral early stage lung cancer treated with stereotactic ablative radiotherapy (SABR), and to identify factors predictive of Common Terminology Criteria of Adverse Events Grade 2 + chest wall pain.